Given the high prevalence of major depression and MetS in the population, we hypothesized that depression symptoms influence metabolic syndrome or its components through the action of inflammatory biomarkers such as hs-CRP and ICAM-1. The gene discussed is ICAM1; the disease is depressive symptom measurement.